NCT07665827Not yet recruiting
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage: A Multicenter, Prospective, Cluster-Randomized, Open-Label, Blinded-Endpoint Clinical Trial
Source: ClinicalTrials.gov · Last updated 24 Jun 2026
Brief summary (registry, in English)
MSU-ICH is a prospective, multicenter, Week-wise-randomized, open-label, blinded-endpoint (PROBE) clinical trial comparing ultra-early prehospital blood pressure lowering delivered by a Mobile Stroke Unit (MSU) with standard Emergency Medical Services (EMS) in patients with spontaneous intracerebral hemorrhage.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 706 (estimated)
- First submitted
- 26 Apr 2026
- Start date
- Jun 2026
- Primary completion date
- Apr 2028
- Lead sponsor
- Xuanwu Hospital, Beijing
- Diseases
- Stroke
- NCT number
- NCT07665827
What you commit to
- Study type: Interventional
- Planned participants: 706
- From Jun 2026 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Contraindications to intensive blood pressure lowering, including severe arterial stenosis or high-grade stenotic valvular heart disease.
- Malignant disease or other serious primary illness with a life expectancy of \<3 months.
Other
- Glasgow Coma Scale (GCS) score ≤5.
- Current participation in another interventional randomized clinical trial.
Who the study is looking for
- History and physical/neurological examination consistent with acute stroke.
- Age ≥18 years;
- Time from symptom onset to enrollment \<3 hours (onset defined as last known normal).
- Systolic blood pressure ≥150 mmHg and ≤220 mmHg;
- Pre-stroke modified Rankin Scale (mRS) score ≤2;
- Informed consent obtained from the subject or a legally authorized representative.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xuanwu Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.